6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation.

Typeset version

 

TY  - CONF
  - Harris, D.M., Fisher, A., Mandel, A., Bolton, A.E., Sullivan, A.M., Nolan, Y.
  - International Congress on Parkinson’s Disease and Related Disorders, Berlin, Germany.
  - 6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation.
  - Berlin, Germany
  - Invited Lectures (Conference)
  - 2005
  - ()
  - 1
  - 05-JUN-05
  - 08-JUN-06
  - Vasogen Ireland Limited
DA  - 2005/NaN
ER  - 
@unpublished{V379685,
   = {Harris,  D.M. and  Fisher,  A. and  Mandel,  A. and  Bolton,  A.E. and  Sullivan,  A.M. and  Nolan,  Y. },
   = {International Congress on Parkinson’s Disease and Related Disorders, Berlin, Germany.},
   = {{6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation.}},
   = {Berlin, Germany},
   = {Invited Lectures (Conference)},
   = {2005},
   = {()},
   = {1},
  month = {Jun},
   = {08-JUN-06},
   = {Vasogen Ireland Limited},
  source = {IRIS}
}
AUTHORSHarris, D.M., Fisher, A., Mandel, A., Bolton, A.E., Sullivan, A.M., Nolan, Y.
TITLEInternational Congress on Parkinson’s Disease and Related Disorders, Berlin, Germany.
PUBLICATION_NAME6-hydroxydopamine-induced degeneration of rat nigral dopaminergic neurons and microglial activation is reduced by treatment with a novel phospholipid-based drug formulation.
LOCATIONBerlin, Germany
CONFERENCE_TYPEInvited Lectures (Conference)
YEAR2005
TIMES_CITED()
PEER_REVIEW1
START_DATE05-JUN-05
END_DATE08-JUN-06
ABSTRACT
FUNDED_BYVasogen Ireland Limited